Clinical research status of iridocorneal endothelial syndrome
Author:
Corresponding Author:

Affiliation:

Clc Number:

Fund Project:

National Natural Science Foundation of China(No.81770948); Fujian Provincial Science and Technology Innovation Leadership Talent Foundation(No.2016B011)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Iridocorneal endothelial(ICE)syndrome presents a group of ocular pathologies mostly characterized by corneal endothelial abnormalities and iris atrophy. Iridocorneal endothelial syndrome is typically a unilateral and generally not involving genetic condition, frequently affecting women in early to middle adulthood. There is no treatment for absence of symptoms in early stages. When complicated with corneal edema and secondary glaucoma, treatment is mainly symptomatic. In this group of diseases, there are many similarities and some differences in their pathogenesis, clinical manifestations and treatment. So far no universal information on these features has been published. Recent clinical studies on iridocorneal endothelial syndrome are reviewed in this paper.

    Reference
    Related
    Cited by
Get Citation

Yu-Lin Shi, Guo-Xing Xu. Clinical research status of iridocorneal endothelial syndrome. Guoji Yanke Zazhi( Int Eye Sci) 2020;20(8):1351-1354

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:May 16,2019
  • Revised:June 28,2020
  • Adopted:
  • Online: July 22,2020
  • Published: